Peroxynitrite and cardiomyocyte cell death: an evolving story. A commentary on "Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo"

Free Radical Biology and Medicine

Volumn 41, Issue 6, 2006, Pages 866-868

  Obrosova, Irina G ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA FRAGMENT; FREE RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITROSAMINE; PEROXYNITRITE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRUCTURE; CYTOTOXICITY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME DEGRADATION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 33747378288     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.06.009     Document Type: Note

References (32)

1. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271 (1996) C1424-C1437
2. Obrosova I.G., Mabley J.G., Zsengeller Z., Charniauskaya T., Abatan O.I., Groves J.T., and Szabo C. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J. 19 (2005) 401-403
3. Szabo G., and Bahrle S. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury. Curr. Vasc. Pharmacol. 3 (2005) 215-220
4. Rubbo H., and O'Donnell V. Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights. Toxicology 208 (2005) 305-317
5. Ischiropoulos H., and Beckman J.S. Oxidative stress and nitration in neurodegeneration: cause, effect, or association?. J. Clin. Invest. 111 (2003) 163-169
6. Evgenov O.V., and Liaudet L. Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock. Curr. Vasc. Pharmacol. 3 (2005) 293-299
7. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4003-4008
8. Denicola A., and Radi R. Peroxynitrite and drug-dependent toxicity. Toxicology 208 (2005) 273-288
9. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem. Biophys. Res. Commun. 305 (2003) 776-783
10. Virag L., Szabo E., Gergely P., and Szabo C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol. Lett. 140-141 (2003) 113-124
11. Szabo C. Poly(ADP-ribose) polymerase activation by reactive nitrogen species-Relevance for the pathogenesis of inflammation. Nitric Oxide 14 (2006) 169-179
12. Li M.H., Cha Y.N., and Surh Y.J. Carbon monoxide protects PC12 cells from peroxynitrite-induced apoptotic death by preventing the depolarization of mitochondrial transmembrane potential. Biochem. Biophys. Res. Commun. 342 (2006) 984-990
13. Fu Y., Sies H., and Lei X.G. Opposite roles of selenium-dependent glutathione peroxidase-1 in superoxide generator diquat- and peroxynitrite-induced apoptosis and signaling. J. Biol. Chem. 276 (2001) 43004-43009
14. Matarrese P., Straface E., Pietraforte D., Gambardella L., Vona R., Maccaglia A., Minetti M., and Malorni W. Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases. FASEB J. 19 (2005) 416-418
15. Zhang X., Chen J., Graham S.H., Du L., Kochanek P.M., Draviam R., Guo F., Nathaniel P.D., Szabo C., Watkins S.C., and Clark R.S. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J. Neurochem. 82 (2002) 181-191
16. Digerness S.B., Harris K.D., Kirklin J.W., Urthaler F., Viera L., Beckman J.S., and Darley-Usmar V. Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radical Biol. Med. 27 (1999) 1386-13892
17. Pacher P., Schulz R., Liaudet L., and Szabo C. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol. Sci. 26 (2005) 302-310
18. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 138 (2003) 532-543
19. Teng R.J., Ye Y.Z., Parks D.A., and Beckman J.S. Urate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration. Free Radic. Biol. Med. 33 (2002) 1243-1249
20. Pacher P., Liaudet L., Bai P., Mabley J.G., Kaminski P.M., Virag L., Deb A., Szabo E., Ungvari Z., Wolin M.S., Groves J.T., and Szabo C. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107 (2003) 896-904
21. Lancel S., Tissier S., Mordon S., Marechal X., Depontieu F., Scherpereel A., Chopin C., and Neviere R. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J. Am. Coll. Cardiol. 43 (2004) 2348-2358
22. Pieper G.M., Nilakantan V., Chen M., Zhou J., Khanna A.K., Henderson Jr. J.D., Johnson C.P., Roza A.M., and Szabo C. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants. J. Pharmacol. Exp. Ther. 314 (2005) 53-60
23. Pacher P., and Szabo C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr. Opin. Pharmacol. 6 (2006) 136-141
24. 2+-ATPase in human heart failure. Circulation 111 (2005) 988-995
25. Mihm M.J., Coyle C.M., Schanbacher B.L., Weinstein D.M., and Bauer J.A. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc. Res. 49 (2001) 798-807
26. Wang W., Sawicki G., and Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc. Res. 53 (2002) 165-174
27. Pesse B., Levrand S., Feihl F., Waeber B., Gavillet B., Pacher P., and Liaudet L. Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21(Ras) in H9C2 cardiomyocytes. J. Mol. Cell. Cardiol. 38 (2005) 765-775
28. Levrand S., Pesse B., Feihl F., Waeber B., Pacher P., Rolli J., Schaller M.D., and Liaudet L. Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines. J. Biol. Chem. 280 (2005) 34878-34887
29. Liaudet L., Szabo E., Timashpolsky L., Virag L., Cziraki A., and Szabo C. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br. J. Pharmacol. 133 (2001) 1424-1430
30. Jagtap P., and Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discovery 4 (2005) 421-440
31. S. Levrand, Vannay-C. Bouchiche, B. Pesse, P. Pacher, F. Feihl, B. Waeber, L. Liaudet, Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic. Biol. Med. (in press)
32. Yaoita H., Ogawa K., Maehara K., and Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97 (1998) 276-281